A new AI tool developed by King’s College London and University College London (UCL) researchers can detect “invisible brain abnormalities” in people with epilepsy. It could change the care of 30,000 patients annually in the UK and save the National Health Service up to £55,000 ($70,000) per patient, said researchers.
New AI Tool Spots ‘Invisible’ Epilepsy Brain Lesions Missed By Radiologists
Neural Network Tool Identifies Epilepsy-Causing Focal Cortical Dysplasia Lesions
MELD Graph could help speed up the diagnosis and treatment of people with epilepsy by spotting "invisible" brain lesions often missed by radiologists. The new open-source AI tool developed by UK researchers could save the NHS up to $70,000 per patient, said researchers.

More from R&D
More from Market Intelligence
Implementing a reflex test alongside traditional prostate cancer screening is cost-effective for high-risk groups, claims Prostate Cancer Research. Oxford BioDynamics sheds light on UK market conditions influencing the adoption of its reflex test, EpiSwitch PSE.
Several counties in the US state of Georgia are maternity care “deserts.” Remote monitoring of high-risk pregnancies with maternal hypertension and diabetes could help improve the state’s high rate of maternal mortality, according to leading health service provider Philips.
Medtronic’s US FDA approval for BrainSense aDBS and BrainSense EI software features of the Percept neurostimulator device has quickly followed CE marking in January.